Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C16H18N2O |
Molecular Weight | 254.3269 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC3=CNC4=C3C(=CC=C4)C1=C[C@@H](CO)CN2C
InChI
InChIKey=BIXJFIJYBLJTMK-MEBBXXQBSA-N
InChI=1S/C16H18N2O/c1-18-8-10(9-19)5-13-12-3-2-4-14-16(12)11(7-17-14)6-15(13)18/h2-5,7,10,15,17,19H,6,8-9H2,1H3/t10-,15-/m1/s1
Molecular Formula | C16H18N2O |
Molecular Weight | 254.3269 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Lysergol {LYZ; (7-methyl-
4,6,6a,7,8,9-hexahydro-indolo[4,3-fg]quinolin-9-yl)-methanol} has shown potential to enhance BA of berberine (poorly water soluble herbal anticancer agent). It is obtained from the
seeds of Ipomoea muricata, I. turbinate and Calonyction muricata
belonging to the family Convolvulaceae. Seeds are commonly
known as ‘Kaladana’ in trade and are being used as a purgative
in India and Pakistan. LYZ is an indole alkaloid present in the
microfungi of Claviceps purpurea as well. It is one of the minor
constituents of the ancient Mexican hallucinogenic drug
Ololiuqui, which is obtained from Rivea corymbosa seeds. LYZ
has been used by the 17th century midwives to induce labour
and stop postpartum bleeding because of its ability to induce uterine contractions. It may also cause ergot poisoning, diarrhea,
hallucinations, delirium, seizures, burning sensations,
and gangrene in the limbs. However, it is not being used
presently in the clinic.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL214 |
2.3 nM [Ki] | ||
1.6 nM [EC50] | |||
6.6 nM [EC50] | |||
Target ID: CHEMBL1833 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22982401 |
199.0 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Two amino acid differences in the sixth transmembrane domain are partially responsible for the pharmacological differences between the 5-HT1D beta and 5-HT1E 5-hydroxytryptamine receptors. | 1996 Nov |
|
Total synthesis of (+/-)-lysergic acid, lysergol, and isolysergol by palladium-catalyzed domino cyclization of amino allenes bearing a bromoindolyl group. | 2008 Nov 20 |
|
Large-scale separation of clavine alkaloids from Ipomoea muricata by pH-zone-refining centrifugal partition chromatography. | 2009 Jun 15 |
|
Enantioselective synthesis of (+)-isolysergol via ring-closing metathesis. | 2010 Jun 4 |
|
Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. | 2011 Jul 14 |
Patents
Sample Use Guides
The PK study of CUR in male Sprague Dawley rats at 100 mg/kg
was performed with and without coadministration of Lysergol (LYZ) (20 mg/kg) and the results revealed that the animals tolerated the treatment as no peculiarities in their behavior were observed.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24410373
Lysergol yielded 98.20% binding inhibition against 5-HT1A receptor at
10 uM and its Ki value was found to be 2.3 nM afterward.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 14:57:45 GMT 2023
by
admin
on
Fri Dec 15 14:57:45 GMT 2023
|
Record UNII |
NTR684Z1AZ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
NTR684Z1AZ
Created by
admin on Fri Dec 15 14:57:45 GMT 2023 , Edited by admin on Fri Dec 15 14:57:45 GMT 2023
|
PRIMARY | |||
|
1413-67-8
Created by
admin on Fri Dec 15 14:57:45 GMT 2023 , Edited by admin on Fri Dec 15 14:57:45 GMT 2023
|
PRIMARY | |||
|
LYSERGOL
Created by
admin on Fri Dec 15 14:57:45 GMT 2023 , Edited by admin on Fri Dec 15 14:57:45 GMT 2023
|
PRIMARY | |||
|
14987
Created by
admin on Fri Dec 15 14:57:45 GMT 2023 , Edited by admin on Fri Dec 15 14:57:45 GMT 2023
|
PRIMARY |